Pharma

Global Meets Local in Austria

Codexis Sees Success in Pharma Business...

Chemical Industry’s Expectations for the U.S. Business Climate in 2013

Consumer Healthcare

Social Media in Pharmaceutical Companies

Saltigo Realigns Strategy

Saltigo, the custom manufacturing business of Lanxess' Advanced Intermediates segment, which achieved total sales of €1.5 billion in 2011, has realigned its strategy.

Manufacturing of HPAPIs and ADC Toxins for the Drugs of Tomorrow

India and China support Contract Manufacturing

PharmaChemical Ireland Strategy on Track

Expect More

The Future of Fine Chemical Production

Changing Times

Impact of New Regulations on Global Antibiotics Production

Learning From The Cliff

Siegfried acquires Alliance Medical Products

Valeant Withdraws Its Bid For ISTA Pharmaceuticals

What Pharma Can Learn from the Tobacco Industry

Interoperability in the Pharma Supply Chain

Saltigo Examines the State of Custom Manufacturing in the New Year

Optimism Springs Eternal - 2011 was a year fraught with uncertainties, and many industries are wearily eyeing the year to come.

EU Agency Issues Guideline on Biosimilar MS Drugs

Counterfeit Pharmaceuticals

Pharma Asks The Money Question Earlier For New Drugs

AstraZeneca, Novartis and Sanofi Douse Hopes For New Drugs

Healthcare Reform in the U.S.: What Supreme Court Ruling Could Mean

All-round Pharma Service Providers See Potential in Asia, Elsewhere

Hikma Pharma, Vifor Pharma Enter into Licensing, Distribution Deal

Bristol-Myers Sees Q2 Profit Drop

Sanofi-Aventis Q2 Profit Slips

Pharmaceutical Product Development Q2 Profit Rises

GlaxoSmithKline Swings to Profit In Q2

Bristol-Myers to Acquire Amira Pharma For $325 Million

Abbott Laboratories Q2 Profit Surges 50%

Merck Inks New Non-Exclusive Agreement With Roche

Forest Labs Q1 Profit Tops Views

Johnson & Johnson Q2 Profit Down